Loading...

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

AIMS: We investigated clinical characteristics and outcomes of patients with significant valvular disease (SVD) in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) trial. METH...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur Heart J
Main Authors: Breithardt, Günter, Baumgartner, Helmut, Berkowitz, Scott D., Hellkamp, Anne S., Piccini, Jonathan P., Stevens, Susanna R., Lokhnygina, Yuliya, Patel, Manesh R., Halperin, Jonathan L., Singer, Daniel E., Hankey, Graeme J., Hacke, Werner, Becker, Richard C., Nessel, Christopher C., Mahaffey, Kenneth W., Fox, Keith A. A., Califf, Robert M.
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4265383/
https://ncbi.nlm.nih.gov/pubmed/25148838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehu305
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!